James Perkins to Liver Transplantation
This is a "connection" page, showing publications James Perkins has written about Liver Transplantation.
Connection Strength
8.703
-
Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies. JAMA Surg. 2023 06 01; 158(6):610-616.
Score: 0.497
-
New Evidence Supporting Increased Use of Split Liver Transplantation. Transplantation. 2020 02; 104(2):299-307.
Score: 0.395
-
Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant. Clin Transplant. 2015 Jan; 29(1):60-6.
Score: 0.276
-
The HALOS-ND model: a step in the journey of predicting hospital length of stay after liver transplantation. Clin Transplant. 2013 Nov-Dec; 27(6):809-22.
Score: 0.253
-
Treatment of an elderly patient with hepatocellular carcinoma: counseling from the patient's point of view. Liver Transpl. 2012 Apr; 18(4):391-4.
Score: 0.229
-
Impact of obesity on children undergoing liver transplantation. Liver Transpl. 2010 Nov; 16(11):1296-302.
Score: 0.208
-
Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation. J Am Med Inform Assoc. 2010 Jul-Aug; 17(4):396-402.
Score: 0.203
-
Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation. HPB (Oxford). 2010 Apr; 12(3):166-73.
Score: 0.200
-
The impact of consecutive operations on survival after liver transplantation. Liver Transpl. 2009 Aug; 15(8):907-14.
Score: 0.191
-
Another formula to determine the prognosis of patients with acute liver failure. Liver Transpl. 2009 Aug; 15(8):986-91.
Score: 0.191
-
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clin Transplant. 2009 Nov-Dec; 23(6):874-81.
Score: 0.187
-
Should liver transplantation in patients with model for end-stage liver disease scores
View in: PubMed
Score: 0.184
D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009 Feb; 9(2):318-26.
Score: 0.183
Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies. Liver Transpl. 2008 Jul; 14(7):956-65.
Score: 0.177
New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant. 2008 Aug; 8(8):1639-51.
Score: 0.176
Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients. Liver Transpl. 2007 Apr; 13(4):516-22.
Score: 0.162
The role of Foxp3+ regulatory T cells in liver transplant tolerance. Transplant Proc. 2006 Dec; 38(10):3205-6.
Score: 0.158
Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance. Transplant Proc. 2006 Dec; 38(10):3207-8.
Score: 0.158
Acute liver failure in children: they really are not just small adults. Liver Transpl. 2006 Nov; 12(11):1715-6.
Score: 0.158
The influence of CTLA-4 gene polymorphisms on liver transplant outcomes. Liver Transpl. 2006 Oct; 12(10):1552-3.
Score: 0.157
Using extended criteria donor (ECD) livers: three strikes and you're almost out. Liver Transpl. 2006 Oct; 12(10):1554-5.
Score: 0.157
A modified stenting procedure for bile duct reconstruction. Liver Transpl. 2006 Sep; 12(9):1431-2.
Score: 0.156
Hepatic arterial vasospasm early after liver transplantation? Liver Transpl. 2006 Sep; 12(9):1433-4.
Score: 0.156
Aprotinin: effective, but risky? Liver Transpl. 2006 Aug; 12(8):1293-4.
Score: 0.155
Steroid use in liver transplantation: none, perioperative, or full course. Liver Transpl. 2006 Aug; 12(8):1294-5.
Score: 0.155
A new reason for intraoperative blood flow measurement: improving liver allograft function. Liver Transpl. 2006 Aug; 12(8):1295-6.
Score: 0.155
Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transpl. 2006 Jun; 12(6):1012-3.
Score: 0.153
Treatment strategies for posttransplant lymphoproliferative disorder. Liver Transpl. 2006 Jun; 12(6):1013-4.
Score: 0.153
Immediate tracheal extubation following liver transplantation. Liver Transpl. 2006 May; 12(5):883-4.
Score: 0.152
To biopsy or not to biopsy? Liver Transpl. 2006 May; 12(5):885-6.
Score: 0.152
Old foe learns new tricks. Liver Transpl. 2006 Apr; 12(4):683.
Score: 0.151
Predicting posttransplantation infection risk with gene polymorphisms. Liver Transpl. 2006 Mar; 12(3):488-9.
Score: 0.150
Percutaneous transhepatic balloon dilation for portal venous stenosis. Liver Transpl. 2006 Feb; 12(2):321-2.
Score: 0.150
Hemochromatosis and liver transplant survival. Liver Transpl. 2006 Feb; 12(2):322.
Score: 0.150
Using root cause analysis to improve survival in a liver transplant program. J Surg Res. 2005 Nov; 129(1):6-16.
Score: 0.145
Optimizing pediatric liver transplantation: Evaluating the impact of donor age and graft type on patient survival outcome. Pediatr Transplant. 2024 Jun; 28(4):e14771.
Score: 0.133
A retrospective cohort study of socioeconomic deprivation and post-liver transplant survival in adults. Liver Transpl. 2024 Aug 01; 30(8):816-825.
Score: 0.130
Maximizing utility of nondirected living liver donor grafts using machine learning. Front Immunol. 2023; 14:1194338.
Score: 0.125
Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2022 03; 28(3):407-421.
Score: 0.112
Do funding sources influence long-term patient survival in pediatric liver transplantation? Pediatr Transplant. 2021 03; 25(2):e13887.
Score: 0.104
Expanding Blood Type A2-to-B Liver Transplantation: An Alternative for High Model for End-Stage Liver Disease Score Patients. Liver Transpl. 2020 11; 26(11):1532-1533.
Score: 0.103
Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database. Clin Transplant. 2020 10; 34(10):e14031.
Score: 0.102
Livers From Pediatric Donation After Circulatory Death Donors Represent a Viable and Underutilized Source of Allograft. Liver Transpl. 2020 09; 26(9):1138-1153.
Score: 0.102
Adults transplanted as children as retransplant candidates: Analysis of outcomes support optimism in a population mislabeled as high risk. Clin Transplant. 2020 07; 34(7):e13880.
Score: 0.101
The impact of public health service increased risk donors in pediatric liver transplantation. Pediatr Transplant. 2020 06; 24(4):e13712.
Score: 0.100
Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients. Liver Transpl. 2019 04; 25(4):580-587.
Score: 0.093
Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors? Am J Transplant. 2018 10; 18(10):2604-2605.
Score: 0.090
A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization. Vox Sang. 2018 Apr; 113(3):268-274.
Score: 0.086
Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. Clin Transplant. 1997 Aug; 11(4):328-33.
Score: 0.083
PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Transplant Proc. 2013 Jun; 45(5):1853-5.
Score: 0.062
Hepatic artery thrombosis and liver malignancy in pediatric liver transplantation. J Pediatr Surg. 2012 Jun; 47(6):1255-60.
Score: 0.058
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology. 2012 Jul; 56(1):28-38.
Score: 0.058
Identifying the futile pediatric liver re-transplant in the PELD era. Pediatr Transplant. 2010 Dec; 14(8):1019-29.
Score: 0.052
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010 Jul; 16(7):874-84.
Score: 0.051
Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology. 2010 Jul 05; 402(2):248-55.
Score: 0.050
Liver transplantation at the extremes of the body mass index. Liver Transpl. 2009 Aug; 15(8):968-77.
Score: 0.048
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl. 2008 May; 14(5):604-10.
Score: 0.044
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008 May; 134(5):1342-51.
Score: 0.043
Abdominal compartment syndrome: is the liver involved? Liver Transpl. 2006 Oct; 12(10):1555-6.
Score: 0.039
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation. 2006 Jun 27; 81(12):1645-52.
Score: 0.038
Rescue of acute portal vein thrombosis after liver transplantation using a cavoportal shunt at re-transplantation. Am J Transplant. 2001 Sep; 1(3):284-7.
Score: 0.028
Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology. 1997 Dec; 26(6):1646-52.
Score: 0.021
Advancing the high throughput identification of liver fibrosis protein signatures using multiplexed ion mobility spectrometry. Mol Cell Proteomics. 2014 Apr; 13(4):1119-27.
Score: 0.016